This case study presents a patient with multiple myeloma whose serum specimen exhibits 2 distinct bands in serum protein electrophoresis but only one band in immunofixation electrophoresis. This latter, single band corresponds to the M-spike. An investigation is presented to determine the identity of this disappearing or phantom band. Furthermore, this case is used as a teaching point to explain the criteria used for staging multiple myeloma, how a cell can become a myeloma propagating cell, methods that can be used to identify unexpected bands in serum protein electrophoresis, possible explanations for bands in the beta region, the usual treatment regimens in multiple myeloma and finally specimen collecting and handling procedures for serum protein electrophoresis.
Clinical History

Patient
A 64-year old African American man.
Chief Complaint
Chest pain.
History of Present Illness
The patient presented with right-sided, nonradiating chest pain that he reported had been coming and going, beginning 4 days before arrival. He reported mild shortness of breath, fatigue, nausea, headache, and chills. Also, he reported to have lost 3.63 kg in the week before arrival. Electrocardiogram results revealed normal sinus rhythm with normal axis, and chest x-ray demonstrated an absence of pleural effusions or consolidation.
Past Medical History
No past medical or surgical history available for this patient.
Principal Laboratory Findings
Laboratory values were notable for leukocytosis and elevated platelet-associated antibody immunoglobulin (Ig)G concentrations. Serum protein electrophoresis (SPE) performed on specimens from the patient revealed elevated serum α 2 -globulins, β-globulins, and γ-globulins ( Figure 1A) . A sharp band ( Figure 1B , lane 6) was noted in the β-γ region, and a less-intense band was identified in the γ-region. The results of a corresponding serum immunofixation electrophoresis (IFE) procedure revealed a monoclonal IgG κ band in the gamma region ( Figure 1C) .
Results of Additional Diagnostic Procedures
Results of a pulmonary angiogram showed mottled appearance of the thoracic spine without compression deformity. Bone marrow biopsy revealed variably cellular marrow, ranging from 50% to 90%, with an overall cellularity of 60% to 70%. The marrow was infiltrated with sheets of plasma cells (approximately 70% to 80% of the total cellularity). Flow cytometric testing revealed the presence of a small population of plasma cells with cytoplasmic κ-light chain restriction that was compatible with plasma-cell neoplasm.
Current Medications and Allergies:
Reported no medication use; no known drug allergies.
Family and Social History
Family history was notable for breast cancer (mother) and throat cancer (father). Social history was pertinent for tobacco use (1 pack/wk for unknown duration) and rare alcohol ingestion. The patient reported no intravenous drug abuse.
Physical Examination Findings
Poor dentition noted. No cervical anterior, axillary, or supraclavicular lymphadenopathy; +S1, +S2 without murmurs, rubs, or gallops on cardiac examination. Lungs were clear to auscultation bilaterally. Abdomen was nontender, with no masses. Extremities were nonedematous, with normal symmetry and range of motion. handling procedures for serum protein electrophoresis and immunofixation?
Possible Answers 4. We performed many investigations to identify the nature of this phantom band. To determine whether this band could indicate fibrinogen, a small amount of dried thrombin powder (Biopharm laboratories), greater than 5000 U per vial placed on the tip of a clean applicator stick, was swirled in an aliquot of the specimen. If fibrinogen was present, a clot would form that could be removed with the stick. There was no clot formation, and when the specimen was electrophoresed on the Helena 5-banded serum protein electrophoresis (SPE) gel (Helena Laboratories), there was no change in the intensity of the band between the specimens treated with and without thrombin, ruling out the presence of any fibrinogen in the specimen ( Figure 2) . In another experiment, β-mercaptoethanol, which is known to cleave disulfide bridges, was mixed with specimen material before running it on the 5-banded SPE gel, to determine whether doing so would affect the appearance of the phantom band; no difference was observed. We were intrigued that we did not observe the band in the Helena Titan Gel formulation, the Helena 6-banded (split ß) formulation, the Helena SPIFE High Res formulation, or the Immunofixation formulation, which also splits the β fraction into 2 peaks. Further, no evidence of the band was observed on the Helena V-8 Capillary Immunodisplacement System. The Titan Gel formulation uses acid blue stain for SPE and immunofixation electrophoresis (IFE), whereas the Helena 5-banded SPE, and 6-banded (split ß) SPE use acid blue stain, and the IFE is stained with acid violet stain.
Acid dyes contain anionic constituents, such as sulphonic or carboxylic groups, and are widely used in microscopic stains. 5 The specific variety used in the Helena SPIFE 3000 is proprietary information; hence, the possible mechanism of the interaction with the components in the band cannot be further elaborated.
Despite that fact, the differences in stain would not explain why the band appears on one gel and not the other because both stains are nonspecific protein stains that allow the visualization of any protein debris in the gel. The Helena 5-banded SPE gel was also stained with Sudan Red 7B, a lipoprotein stain, but failed to stain this phantom band between the β-and γ-fractions. Sudan Red 7B is a member of the Sudan family of hydrophobic lipid-staining dyes that are structurally classified as diazo dyes. 6 It is possible that this band was simply debris stuck at the application site because the band did not appear to migrate far from the application site ( Figure 2A ). To investigate this possibility, the specimen was run on the Titan Gel formulation which uses a different application site but the same acid blue stain. We did not observe this phantom band, which ruled out that possibility ( Figure 2B ). Because the formulation of the gels is proprietary information, it was not possible to further investigate the differences in compositions. However, separation of proteins during electrophoresis involves migration dependent on their mass-to-charge ratio and interactions with the electrophoresing medium. When nonspecific protein stains are used for visualization, the generation of artefacts cannot be ruled out.
5. The β-globulin fraction consists of transferrin, haptoglobin, fibrinogen, C3, C4, and β 1 -lipoprotein. The presence of β 1 -lipoprotein in the β-region of serum protein electrophoresis can sometimes be observed as an intense, sharp, often irregular band. Its location in the gel depends on its concentration (ranging from 57 to 206 mg/dL in adults) because its migration decreases with increasing concentration. This property causes it to be anodal to the transferrin band or cathodal to C3 complement.
5
Immunoglobulin (Ig)A and IgM monoclonal gammopathic manifestations also display a similar irregularity due to their tendency to aggregate when present in high concentrations. 7 Fibrinogen, present in a plasma specimen, can also yield a pseudo M-spike between the β-and γ-regions. The fully humanized IgG1κ monoclonal antibody (daratumumab) directed against cluster of differentiation (CD)38 and used to treat multiple myeloma has also been shown to yield a false M-spike. 6. The treatment of symptomatic multiple myeloma is complex and depends on a number of factors, including but not limited to age, disease extent, risk stratification, eligibility for autologous hematopoietic cell transplantation (HCT), renal function, other comorbidities, and the resources available for treatment. Initial therapies often include the use of bortezomib, lenalidomide, cyclophosphamide, and low-dose dexamethasone. Hematopoietic cell transplantation is also part of the algorithm for certain eligible patients. Maintenance therapy is often bortezomib-based or lenalidomide-based and depends on the type of initial therapy and response to therapy. 9 7. The name of the patient and another acceptable identifier should be verified, and the specimen should be collected in a serum separator tube (gold top), ideally, for serum protein electrophoresis (SPE) and immunofixation electrophoresis (IFE). Plasma specimens with ethylenediaminetetraacetic acid (EDTA; lavender top) should not be used because the presence of fibrinogen in plasma will stain, producing a pseudo M-spike and thus necessitating immunofixation to confirm the result and to identify the type of monoclonal gammopathic manifestation. Urine specimens for urine protein electrophoresis and urine IFE can be collected in a container without additives.
If specimens from the same patient on different occasions yield unexpected (extra bands) in their SPE profile, the identity of the patient and the integrity of the specimen should be confirmed. The specimen should be retested (if possible) and/or a new specimen could be requested, to re-run the test. Unexpected bands may occur in the same patient specimen after autologous stem-cell transplantation, which may be an indication of immunoglobulin isotype switch and/or immune reconstitution. This case also highlights how different gel formulations can cause unexpected bands in SPE and shows the importance of re-running the patient specimen using different gel formulations.LM
